clear search
Search
Search Suggestions
Recent searches Clear History
Talk with Us

Episode 055

Food Allergy and EoE: Smarter Diagnosis for Better Care (ft. Anna Nowak-Wegrzyn, MD, PhD)

Episode summary

In this episode, we invite Dr. Anna Nowak-Wegrzyn, a leading researcher in food allergy and Director of Pediatric Allergy and Immunology Division at NYU Grossman School of Medicine, to help unpack the core clinical challenge of distinguishing true food allergy from sensitization, and discuss practical approaches to history-directed testing, component-resolved diagnostics, baked milk and egg tolerance, oral immunotherapy, and eosinophilic esophagitis recognition in atopic patients. We also highlight how primary care can help identify higher-risk patients earlier, improve referral decisions, and support more precise management using evolving diagnostic tools. For clinicians caring for children and adults with allergy, this conversation offers actionable insights for diagnosis, risk stratification, and day-to-day management.

Guest spotlight

Anna Nowak-Wegrzyn, MD, PhD

Dr. Nowak-Wegrzyn is an internationally recognized leader in pediatric allergy and immunology and serves as Professor of Pediatrics and Director of the Pediatric Allergy and Immunology Division at NYU Grossman School of Medicine. She’s widely known for her groundbreaking work in food allergy — particularly in oral immunotherapy and in advancing our understanding of food protein-induced enterocolitis syndrome, or FPIES. Her research has helped shape how we diagnose, manage, and even treat food allergies around the world.

Episode resources

Find the resources mentioned in this episode

Lab Ordering Guide

Looking for allergy diagnostic codes from the labs you already use?

Episode transcript

Time stamps

01:32 – Food Allergy Motivation  

06:11 – Test Interpretation Pitfall  

08:19 – History Directed Testing  

10:52 – Components And Risk Stratification 

14:03 – Baked Milk Egg  

18:02 – OIT And Tolerance  

22:01 – EoE Overview  

26:54 – EoE Screening  

34:12 – Future Therapies  

39:08 – AI And Biomarkers

References used in this episode
  • Portnoy JM. Appropriate allergy testing and interpretation. Mo Med. 2011 Sep-Oct;108(5):339-43. PMID: 22073491; PMCID: PMC6188374.
  • “Eczema (Atopic Dermatitis).” National Institute of Allergy and Infectious Diseases, U.S. Department of Health and Human Services, https://www.niaid.nih.gov/diseases-conditions/eczema-atopic-dermatitis. Accessed 7 May 2026
  • AAAAI/ACAAI JTF Atopic Dermatitis Guideline Panel; Chu DK et al. Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE- and Institute of Medicine-based recommendations. Ann Allergy Asthma Immunol. 2024 Mar;132(3):274-312.
  • Dramburg S. et al. EAACI Molecular Allergology User's Guide 2.0. Pediatr Allergy Immunol. 2023 Mar;34 Suppl 28:e13854.
  • Dantzer JA, et al. Clinical and immunological outcomes after randomized trial of baked milk oral immunotherapy for milk allergy. JCI Insight. 2025 Jan 9;10(1):e184301
  • Furuta GT, Katzka DA. Eosinophilic Esophagitis. N Engl J Med. 2015 Oct 22;373(17):1640-8. [00:22:25]
  • Nowak-Wegrzyn A, Berin MC, Mehr S. Food Protein-Induced Enterocolitis Syndrome. J Allergy Clin Immunol Pract. 2020 Jan;8(1):24-35.
  • Chan KR, et al. Prevalence of atopic dermatitis in the United States from 2021 to 2024: Data from the National Health Interview Survey. J Am Acad Dermatol. 2026 Feb;94(2):633-635.
  • Arroliga, Mercedes. “Are Allergies Genetic? How Family History Impacts Your Health.” Baylor Scott & White Health, 2025, https://www.bswhealth.com/blog/are-allergies-genetic
  • Davis EC, Monaco CL, Insel R, Järvinen KM. Gut microbiome in the first 1000 days and risk for childhood food allergy. Ann Allergy Asthma Immunol. 2024 Sep;133(3):252-261.
  • Goktas P, Damadoglu E. Future of allergy and immunology: Is artificial intelligence the key in the digital era? Ann Allergy Asthma Immunol. 2025 Apr;134(4):396-407.e2.